While past research has demonstrated MAAT can help improve cognitive symptoms among cancer survivors, we are interested in evaluating how MAAT works for survivors not carefully selected for randomized clinical trials—that is, survivors who are engaged in MAAT with their cancer professional in clinical practice.
Currently, we have 10 cancer centers and other cancer services with professionals who have been or are planning to be trained in MAAT. We are asking survivors who are enrolled in MAAT to complete an anonymous questionnaire about their cancer, as well as a short cognitive symptom questionnaire (also anonymous) just before each MAAT visit.
Please note: This study is only open to those survivors enrolled in MAAT at one of the above cancer centers.
The MAAT Outcomes Study Principal Investigator is Dr. Robert J. Ferguson at UPMC Hillman Cancer Center and University of Pittsburgh School of Medicine. The program is funded by a grant from The Beckwith Institute.
If you are a psychologist or other health care professional with CBT experience interested in MAAT training, please contact us.
Currently, we have 10 cancer centers and other cancer services with professionals who have been or are planning to be trained in MAAT. We are asking survivors who are enrolled in MAAT to complete an anonymous questionnaire about their cancer, as well as a short cognitive symptom questionnaire (also anonymous) just before each MAAT visit.
Please note: This study is only open to those survivors enrolled in MAAT at one of the above cancer centers.
The MAAT Outcomes Study Principal Investigator is Dr. Robert J. Ferguson at UPMC Hillman Cancer Center and University of Pittsburgh School of Medicine. The program is funded by a grant from The Beckwith Institute.
If you are a psychologist or other health care professional with CBT experience interested in MAAT training, please contact us.